These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38737697)

  • 1. RBM39 is a potential prognostic biomarker with functional significance in hepatocellular carcinoma.
    Cui F; Wang W; Zhuang C; He D; Wang P
    Transl Cancer Res; 2024 Apr; 13(4):1606-1622. PubMed ID: 38737697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer.
    Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M
    Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell division cycle-associated 8 is a prognostic biomarker related to immune invasion in hepatocellular carcinoma.
    Wu H; Liu S; Wu D; Zhou H; Sui G; Wu G
    Cancer Med; 2023 Apr; 12(8):10138-10155. PubMed ID: 36855818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.
    Ma C; Kang W; Yu L; Yang Z; Ding T
    Front Oncol; 2020; 10():590006. PubMed ID: 33363020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification METTL18 as a Potential Prognosis Biomarker and Associated With Immune Infiltrates in Hepatocellular Carcinoma.
    Li TH; Qin C; Zhao BB; Cao HT; Yang XY; Wang YY; Li ZR; Zhou XT; Wang WB
    Front Oncol; 2021; 11():665192. PubMed ID: 34123827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
    Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
    World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of
    Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G
    Front Genet; 2022; 13():959832. PubMed ID: 36299588
    [No Abstract]   [Full Text] [Related]  

  • 8. Over-expression of RRM2 predicts adverse prognosis correlated with immune infiltrates: A potential biomarker for hepatocellular carcinoma.
    Qin Z; Xie B; Qian J; Ma X; Zhang L; Wei J; Wang Z; Fan L; Zhu Z; Qian Z; Yin H; Zhu F; Tan Y
    Front Oncol; 2023; 13():1144269. PubMed ID: 37056349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of prognostic value and immunological roles of RAB22A in hepatocellular carcinoma.
    Wen F; Meng F; Li X; Li Q; Liu J; Zhang R; Zhao Y; Zhang Y; Wang X; Ju S; Cui Y; Lu Z
    Front Immunol; 2023; 14():1086342. PubMed ID: 36936971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centromere protein N may be a novel malignant prognostic biomarker for hepatocellular carcinoma.
    Wang Q; Yu X; Zheng Z; Chen F; Yang N; Zhou Y
    PeerJ; 2021; 9():e11342. PubMed ID: 33987018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CELSR3 mRNA expression is increased in hepatocellular carcinoma and indicates poor prognosis.
    Gu X; Li H; Sha L; Mao Y; Shi C; Zhao W
    PeerJ; 2019; 7():e7816. PubMed ID: 31608178
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver-specific lncRNA FAM99A may be a tumor suppressor and promising prognostic biomarker in hepatocellular carcinoma.
    Mo M; Ma X; Luo Y; Tan C; Liu B; Tang P; Liao Q; Liu S; Yu H; Huang D; Zeng X; Qiu X
    BMC Cancer; 2022 Oct; 22(1):1098. PubMed ID: 36289466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulated CANT1 is correlated with poor prognosis in hepatocellular carcinoma.
    Liu T; Li ZZ; Sun L; Yang K; Chen JM; Han XY; Qi LM; Zhou XG; Wang P
    BMC Cancer; 2023 Oct; 23(1):1007. PubMed ID: 37858061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of Ribosomal Protein S6 Kinase A4 (RPS6KA4) Predicts a Poor Prognosis in Hepatocellular Carcinoma Patients: A Study Based on TCGA Samples.
    Lu Y; Ren X; Zhou C; Chen H; Fan Y; Wang C
    Comb Chem High Throughput Screen; 2022; 25(13):2165-2179. PubMed ID: 35232347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased CDCA2 Level Was Related to Poor Prognosis in Hepatocellular Carcinoma and Associated With Up-Regulation of Immune Checkpoints.
    Tang M; Liao M; Ai X; He G
    Front Med (Lausanne); 2021; 8():773724. PubMed ID: 35372372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma.
    Su J; Huang Y; Wang Y; Li R; Deng W; Zhang H; Xiong H
    Cancer Cell Int; 2022 Feb; 22(1):67. PubMed ID: 35139863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of NOP58 as a Prognostic Marker in Hepatocellular Carcinoma: A TCGA Data-Based Analysis.
    Wang J; Huang R; Huang Y; Chen Y; Chen F
    Adv Ther; 2021 Jun; 38(6):3342-3361. PubMed ID: 34014550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DPF2 overexpression correlates with immune infiltration and dismal prognosis in hepatocellular carcinoma.
    Yang K; Nong J; Xie H; Wan Z; Zhou X; Liu J; Qin C; Luo J; Zhu G; Peng T
    J Cancer; 2024; 15(14):4668-4685. PubMed ID: 39006087
    [No Abstract]   [Full Text] [Related]  

  • 19. Exonuclease 1 is a Potential Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma.
    Ma J; Jin J; Lu H; Zhang J; Li Y; Cai X
    Front Mol Biosci; 2022; 9():889414. PubMed ID: 35769911
    [No Abstract]   [Full Text] [Related]  

  • 20. A novel five-gene signature predicts overall survival of patients with hepatocellular carcinoma.
    Wang Z; Pan L; Guo D; Luo X; Tang J; Yang W; Zhang Y; Luo A; Gu Y; Pan Y
    Cancer Med; 2021 Jun; 10(11):3808-3821. PubMed ID: 33934539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.